Open‐label, pilot protocol of patients with rheumatoid arthritis who switch to infliximab after an incomplete response to etanercept: the opposite study
AUTOR(ES)
Furst, Daniel E
FONTE
BMJ Group
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1955098Documentos Relacionados
- Paroxetine in Patients With Irritable Bowel Syndrome: A Pilot Open-Label Study
- Rivastigmine: an open-label, observational study of safety and effectiveness in treating patients with Alzheimer's disease for up to 5 years
- Open-label, clinical phase I studies of tasquinimod in patients with castration-resistant prostate cancer
- Maintenance use of ketamine for treatment-resistant depression: an open-label pilot study
- Open-Label, Dose Escalation Study of the Safety and Pharmacokinetic Profile of Tefibazumab in Healthy Volunteers